Search

everythinglearnresearchcommunity

for

Search:↓

The new compound may be a safer alternative to finasteride for prostate protection.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

A new compound that could treat various androgen-related conditions was created and analyzed.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.

5α-reductases increase epitestosterone's effect on androgen receptors.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Androgens can both increase and decrease hair growth in different parts of the body.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

DHT, a testosterone byproduct, causes male pattern baldness.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Minoxidil boosts enzymes that help hair growth.

Finasteride effectively treats male hair loss, improving growth and density.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

New compounds may soon be tested to treat excessive hair growth in women.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.